Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
12/21/1995 | WO1995034648A1 A method for displaying proteins |
12/21/1995 | WO1995034635A1 Nucleic acid sequences and expression systems for heparinase ii and heparinase iii derived from flavobacterium heparinum |
12/21/1995 | WO1995034581A1 Inhibition of human xenogenic or allogenic antibodies to reduce xenograft or allograft rejection in human recipients |
12/21/1995 | WO1995034580A1 Isolated nucleic acid encoding retinol dehydrogenase |
12/21/1995 | WO1995034578A1 Recombinant allergen, fragments thereof, corresponding recombinant dna molecules, vectors and hosts containing the dna molecules, diagnostic and therapeutic uses of said allergens and fragments |
12/21/1995 | WO1995034558A1 Chondramides, production methods, compositions comprising chondramides and cultures for chondramide production |
12/21/1995 | WO1995034324A1 Cross-reacting monoclonal antibodies specific for e-selectin and p-selectin |
12/21/1995 | WO1995034320A2 Methods for inhibiting antigen specific t cell responses |
12/21/1995 | WO1995034319A1 Compositions and methods for the treatment of tumors |
12/21/1995 | WO1995034201A1 pp60PIK: A DOWNSTREAM ELEMENT IN INSULIN SIGNALING |
12/21/1995 | WO1995033048A3 P2x receptors (purinoceptor family) |
12/21/1995 | WO1995030750A3 Lag-3 protein soluble polypeptide fractions, method of production, therapeutic composition and anti-idiotype antibody |
12/21/1995 | WO1995029245A3 Btf2 complex proteins and uses thereof |
12/21/1995 | WO1995020660A3 Immunization by inoculation of dna transcription unit |
12/21/1995 | CA2193072A1 Corticotropin-releasing factor2 receptors |
12/21/1995 | CA2193060A1 Inhibition of human xenogenic or allogenic antibodies to reduce xenograft or allograft rejection in human recipients |
12/21/1995 | CA2192844A1 Fas associated proteins |
12/21/1995 | CA2192486A1 Pp60pik: a downstream element in insulin signaling |
12/21/1995 | CA2192334A1 Isolated nucleic acid encoding retinol dehydrogenase |
12/21/1995 | CA2192175A1 Surface protein of staphylococcus aureus |
12/21/1995 | CA2191870A1 Cross-reacting monoclonal antibodies specific for e-selectin and p-selectin |
12/21/1995 | CA2191733A1 Methods for inhibiting antigen specific t cell responses |
12/21/1995 | CA2191065A1 Compositions and methods for the treatment of tumors |
12/21/1995 | CA2169358A1 A method for displaying proteins |
12/20/1995 | EP0687303A1 Improved feedcrops enriched in sulfur amino acids and methods for improvement |
12/20/1995 | EP0687302A1 Bi-functional expression system |
12/20/1995 | EP0687301A1 Prohormone convertase transformed cells and polypeptide synthesis |
12/20/1995 | EP0687300A1 LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T-CELL ACTIVATION AND PROLIFERATION |
12/20/1995 | EP0687295A1 Human b-lymphoblastoid cell line secreting anti-ganglioside antibody |
12/20/1995 | EP0687272A1 Method and compositions for recombinant osteogenic protein production |
12/20/1995 | EP0687271A1 Extraction of cell-bound protein from bordetella |
12/20/1995 | EP0669933A4 PURIFICATION OF FUSION PROTEINS COMPRISING GM-CSF and IL-3. |
12/20/1995 | EP0502036B1 Latency associated peptide and uses therefor |
12/20/1995 | EP0394424B1 Peptides and polypeptides from the sub-maxilary gland of the rat, corresponding monoclonal and polyclonal antibodies, corresponding hybridomas and applications of said products to the diagnosis, detection or for therapeutical purposes |
12/20/1995 | CN1113518A A novel peptide related to human programmed cell death and DNA encoding it |
12/20/1995 | CN1030528C Human placenta collagen and preparation thereof |
12/19/1995 | US5476939 Immunoassay for metal ions; forming coordination complexes |
12/19/1995 | US5476786 Host cell harboring and capable of expressing DNA encoding single chain recombinant polypeptide having site for binding preselected antigen |
12/19/1995 | US5476782 DNA encoding a human 5-HT1E receptor and uses thereof |
12/19/1995 | US5476781 Genetic engineering |
12/19/1995 | US5476773 Of protein; then mixing with a reducing sugar |
12/19/1995 | CA2011654C Recombinant poxvirus host range selection system |
12/19/1995 | CA1337759C Glycopeptide antibiotic |
12/19/1995 | CA1337758C Peptide antibiotics |
12/19/1995 | CA1337756C Means and method for preventing and treating graft failure in humans |
12/19/1995 | CA1337755C Monoclonal antibodies for human non-small cell lung carcinomas |
12/18/1995 | CA2151627A1 Recombinant gibberellin dna and uses thereof |
12/15/1995 | CA2150994A1 P53as protein and antibody therefor |
12/14/1995 | WO1995033855A1 Isolated nucleic acid molecule which codes for a tumor rejection antigen precursor, and uses thereof |
12/14/1995 | WO1995033844A1 Method for producing heterologous bispecific antibodies |
12/14/1995 | WO1995033843A1 Deblocking the common pathway of aromatic amino acid synthesis |
12/14/1995 | WO1995033833A1 Yeast strains |
12/14/1995 | WO1995033832A1 Recombinant single chain fv antibody fragment and its use in the immunopurification of the recombinant hepatitis b virus surface antigen |
12/14/1995 | WO1995033831A1 Methods and compositions for modulating morphogenic protein expression |
12/14/1995 | WO1995033830A1 Bmp-9 compositions |
12/14/1995 | WO1995033829A1 Pantropic neurotrophic factors |
12/14/1995 | WO1995033825A1 A method of cultivating bacteria producing proteins that are expressed in a temperature regulated manner |
12/14/1995 | WO1995033823A1 Methods for selectively stimulating proliferation of t cells |
12/14/1995 | WO1995033818A2 Genes for the synthesis of antipathogenic substances |
12/14/1995 | WO1995033772A1 Flt4 receptor tyrosine kinase and its use in diagnosis and therapy |
12/14/1995 | WO1995033771A1 MONOCLONAL ANTIBODY ACTIVE AGAINST CD44v6 |
12/14/1995 | WO1995033770A1 Ligands for induction of antigen specific apoptosis in t cells |
12/14/1995 | WO1995033758A1 Novel glyceroglycophospholipid, antibody there against, and method of detecting mycoplasma |
12/14/1995 | WO1995033481A1 Diphtheria toxin vaccines bearing a mutated r domain |
12/14/1995 | WO1995033480A1 Pigment epithelium-derived factor: characterization, genomic organization and sequence of the pedf gene |
12/14/1995 | WO1995031564A3 Method of introducing pathogen resistance in plants |
12/14/1995 | WO1995030003A3 Morphogenic protein-specific cell surface receptors and uses therefor |
12/14/1995 | CA2704083A1 Pigment epithelium-derived factor: characterization, genomic organization and sequence of the pedf gene |
12/14/1995 | CA2192370A1 Monoclonal antibody active against cd44v6 |
12/14/1995 | CA2192366A1 Genes for the synthesis of antipathogenic substances |
12/14/1995 | CA2191728A1 Isolated nucleic acid molecule which codes for a tumor rejection antigen precursor, and uses thereof |
12/14/1995 | CA2191610A1 Ligands for induction of antigen specific apoptosis in t cells |
12/14/1995 | CA2191586A1 Methods for selectively stimulating proliferation of t cells |
12/14/1995 | CA2191239A1 Diphtheria toxin vaccines bearing a mutated r domain |
12/13/1995 | EP0686696A1 Recombinant single chain Fv antibody fragment and its use in the immunopurification of the recombinant Hepatitis B Virus Surface Antigen |
12/13/1995 | EP0686397A2 Use of chondroitin sulphate proteoglycans for protection of neurons |
12/13/1995 | EP0686260A1 Human carcinoma antigen (hca), hca antibodies, hca immunoassays, methods of imaging and therapy |
12/13/1995 | EP0686203A1 Compounds and methods for the diagnosis, treatment and prevention of diseases of cell death |
12/13/1995 | EP0686195A1 Method and system for enhanced production of commercially important exoproteins in gram-positive bacteria |
12/13/1995 | EP0686194A1 Harp family growth factors, preparation methods therefor and uses thereof |
12/13/1995 | EP0686162A1 Improved method for the refolding of proteins |
12/13/1995 | EP0686161A1 NOVEL HUMAN $g(b) 2? INTEGRIN ALPHA SUBUNIT |
12/13/1995 | EP0686044A1 Inhibition of intimal hyperplasia using antibodies to pdgf receptors |
12/13/1995 | EP0359771B1 Lepidopteran and coleopteran active microorganisms, related insecticide compositions and methods for their production and use |
12/13/1995 | CN1113389A High molecular weight desulphatohirudin |
12/12/1995 | US5475100 An antibody having antigen binding activity and which has a heavy chain constant region into which has been inserted arganine-glycine-aspartic acid and serine amino acid sequence, giving antibody affinity for cells |
12/12/1995 | US5475087 Polypeptides |
12/12/1995 | US5474930 Non-tumorigenic cell lines for expression of genes |
12/12/1995 | US5474925 Creating genetic construction for expression of enzyme in cotton plant, transforming into inheritable material of plant, cultivating plant, harvesting seed floss fiber with enzyme immobilized therein, performing reaction with enzyme catalyst |
12/12/1995 | US5474914 Method of producing secreted CMV glycoprotein H |
12/12/1995 | US5474913 Process for the preparation of motilin-like polypeptide and expression thereof |
12/12/1995 | US5474771 Inhibits T cell activation of B cells ; binds to epitope |
12/12/1995 | CA1337717C Monoclonal antibodies against human necrosis factor (tnf) _ use thereof for detecting tnf in samples, and pharmaceutical compositions containing them |
12/09/1995 | CA2151117A1 A process for producing a thiol protease inhibitor derived from a microorganism belonging to the genus aspergillus |
12/07/1995 | WO1995033297A1 Electromagnetically controlled gear engagement mechanism integrated with a magnetic hysteresis slip clutch |
12/07/1995 | WO1995033059A2 Receptor for oncostatin m |
12/07/1995 | WO1995033057A1 Hybrid molecule of formula gm-csf-l-epo or epo-l-gm-csf for hematopoietic stimulation |
12/07/1995 | WO1995033053A1 Hepatitis c virus asialoglycoproteins |
12/07/1995 | WO1995033052A1 Immunosuppressant target proteins |
12/07/1995 | WO1995033051A1 Tumor necrosis factor receptor-associated factors |